Katrina Y. Glover

2.0k total citations
12 papers, 1.5k citations indexed

About

Katrina Y. Glover is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Katrina Y. Glover has authored 12 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Hepatology. Recurrent topics in Katrina Y. Glover's work include Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Lung Cancer Treatments and Mutations (3 papers). Katrina Y. Glover is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Lung Cancer Treatments and Mutations (3 papers). Katrina Y. Glover collaborates with scholars based in United States and Brazil. Katrina Y. Glover's co-authors include James L. Abbruzzese, Melanie B. Thomas, Romil Chadha, Jeffrey S. Morris, Lee M. Ellis, Michael J. Overman, Scott Kopetz, Robert A. Wolff, Cathy Eng and Ahmed O. Kaseb and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Hepatology.

In The Last Decade

Katrina Y. Glover

12 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrina Y. Glover United States 9 887 800 423 306 287 12 1.5k
Zhong‐Zhe Lin Taiwan 22 498 0.6× 740 0.9× 418 1.0× 224 0.7× 552 1.9× 65 1.5k
Tiziana Pressiani Italy 19 634 0.7× 735 0.9× 353 0.8× 335 1.1× 440 1.5× 76 1.5k
Dalila Sellami United States 17 421 0.5× 411 0.5× 549 1.3× 298 1.0× 289 1.0× 45 1.3k
M. Moscovici United States 11 1.5k 1.7× 462 0.6× 507 1.2× 589 1.9× 330 1.1× 20 2.1k
Ірина Давиденко United States 16 432 0.5× 807 1.0× 403 1.0× 286 0.9× 583 2.0× 33 1.6k
Xiangqun Song China 10 477 0.5× 627 0.8× 235 0.6× 281 0.9× 670 2.3× 14 1.3k
Richard D. Lozano United States 19 556 0.6× 865 1.1× 395 0.9× 208 0.7× 284 1.0× 23 1.8k
Cyril Hatem France 4 657 0.7× 823 1.0× 180 0.4× 113 0.4× 238 0.8× 5 1.3k
Xinyu Bi China 17 400 0.5× 480 0.6× 361 0.9× 110 0.4× 289 1.0× 100 1.2k
Jean-Frédéric Blanc France 8 959 1.1× 332 0.4× 229 0.5× 392 1.3× 229 0.8× 9 1.3k

Countries citing papers authored by Katrina Y. Glover

Since Specialization
Citations

This map shows the geographic impact of Katrina Y. Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina Y. Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina Y. Glover more than expected).

Fields of papers citing papers by Katrina Y. Glover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina Y. Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina Y. Glover. The network helps show where Katrina Y. Glover may publish in the future.

Co-authorship network of co-authors of Katrina Y. Glover

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina Y. Glover. A scholar is included among the top collaborators of Katrina Y. Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina Y. Glover. Katrina Y. Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kee, Bryan K., Jeffrey S. Morris, Rebecca Slack, et al.. (2014). A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan. Supportive Care in Cancer. 23(3). 661–670. 17 indexed citations
3.
Thomas, Melanie B., Jeffrey S. Morris, Romil Chadha, et al.. (2009). Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma. Journal of Clinical Oncology. 27(6). 843–850. 254 indexed citations
4.
Kopetz, Scott, Paulo M. Hoff, Jeffrey S. Morris, et al.. (2009). Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance. Journal of Clinical Oncology. 28(3). 453–459. 376 indexed citations
5.
Blazer, Dan G., Yoji Kishi, Dipen M. Maru, et al.. (2008). Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases. Journal of Clinical Oncology. 26(33). 5344–5351. 430 indexed citations
6.
Hassan, Manal M., Melanie B. Thomas, Steven A. Curley, et al.. (2008). The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States. Journal of Hepatology. 50(2). 334–341. 64 indexed citations
7.
Hassan, Manal M., Margaret R. Spitz, Melanie B. Thomas, et al.. (2008). Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study. International Journal of Cancer. 123(8). 1883–1891. 64 indexed citations
8.
Overman, Michael J., Priyanka Pathak, Romil Chadha, et al.. (2008). Second-Line Chemotherapy Use in Metastatic Colon Cancer Varies by Disease Responsiveness. Clinical Colorectal Cancer. 7(1). 55–59. 7 indexed citations
9.
Kopetz, Scott, Michael J. Overman, David Chang, et al.. (2008). Systematic Survey of Therapeutic Trials for Metastatic Colorectal Cancer: Room for Improvement in the Critical Pathway. Journal of Clinical Oncology. 26(12). 2000–2005. 11 indexed citations
10.
Thomas, Melanie B., Romil Chadha, Katrina Y. Glover, et al.. (2007). Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer. 110(5). 1059–1067. 235 indexed citations
11.
Glover, Katrina Y., et al.. (2004). A review of small-molecule epidermal growth factor receptor-specific tyrosine kinase inhibitors in development for non-small cell lung cancer. Seminars in Oncology. 31(1 Suppl 1). 83–92. 16 indexed citations
12.
Glover, Katrina Y. & Vali A. Papadimitrakopoulou. (2003). Chemoprevention of head and neck cancer. Current Oncology Reports. 5(2). 152–157. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026